We are currently conducting a clinical trial comparing the safety and effectiveness of a topical medication called Thymosin Beta-4 versus placebo for wound healing in patients with epidermolysis bullosa.

Eligible patients include:

Patients older than 2 years of age
Patients with junctional or dystrophic epidermolysis bullosa

The topical medication is provided at no cost to the study participants and is applied to a wound site once a day for up to eight weeks. There will be a total of eight clinic visits, some phone follow-up conversations, and five laboratory evaluations during the study period. Participants will receive $50 for each clinic visit.

If you are interested in participating in our clinical trial study, please contact Dr. Khuu at (650) 725-8839 or email her at for more information.

For further information regarding questions, concerns, or complaints about research, research related injury, and questions about the rights of research participants, please call (650) 723-5244 or call toll free 1-866-680-2906, or write the Administrative Panel on Human Subjects in Medical Research, Administrative Panels Office, Stanford University, Stanford, CA 94305-5401.